Loading data
HHSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 159.57 m USD | 185.24 m USD | 191.49 m USD | 206.28 m USD | 194.6 m USD |
| Selling, general and administrative expense | 22.21 m USD | 22.78 m USD | 20.67 m USD | 21.89 m USD | 17.86 m USD |
| Operating profit | 386 k USD | 2.09 m USD | 3.36 m USD | 15.11 m USD | 7.64 m USD |
| Profit before tax | -1.01 m USD | -37.93 m USD | -1.92 m USD | 19.31 m USD | 16.26 m USD |
| Income tax expense | -197 k USD | -7.64 m USD | -349 k USD | -17.46 m USD | 1.29 m USD |
| Net income (reported basis) | -811 k USD | -811 k USD | -30.3 m USD | -1.57 m USD | 14.97 m USD |
| Net income attributable to common shareholders | — | — | -1.57 m USD | 35.4 m USD | 12.62 m USD |
| Basic earnings per share | -0.11 USD/share | -4.15 USD/share | -0.21 USD/share | 4.98 USD/share | 1.85 USD/share |
| Diluted earnings per share | -0.11 USD/share | -4.15 USD/share | -0.21 USD/share | 4.75 USD/share | 1.76 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.